Continuing Education Instructions and Disclosure Information:
Contact hours available until 12/31/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, and Authors Conflict of Interest Disclosure:
Nancy Albert - Consultant for Novartis & Boston Scientific, research only.
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and AAACN.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
AAACN is a provider approved by the California Board of Registered Nursing, provider number CEP 5366.
After completing this learning activity, the learner will be able to describe disease processes, assessment, and management of chronic illnesses and problems commonly encountered in an ambulatory care setting.
Learning Engagement Activity:
Pharmacotherapeutic agents are important in the management of chronic illnesses. For those chronic diseases described in this chapter, except for developmental delays, identify at least one durg that is used in the treatment and review the mechanism of action.
You must be logged in and own this product in order to post comments.
11/28/22 8:33 pm
It was a very long chapter (100 pages) with a lot of information. While I could do many of the chapters in one sitting, I had to spread this out as it was a lot of info to take in.
3/22/23 4:25 pm
The section on heart failure was the most difficult to read, author did not present the information well. The author put a lot of emphasis on the nurses need to educate oneself regarding diagnostic and medication titration/ management which I feel is inappropriate and requires a NP/PA or MD license.
3/30/23 11:27 am
Reviewed the mechanism for action for fasting acting insulin NovoLog for diabetics.